Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques J Phuah, EA Wong, HP Gideon, P Maiello, MT Coleman, MR Hendricks, ... Infection and immunity 84 (5), 1301-1311, 2016 | 120 | 2016 |
Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis RM DiFazio, JT Mattila, EC Klein, LR Cirrincione, M Howard, EA Wong, ... Fibrogenesis & tissue repair 9, 1-11, 2016 | 65 | 2016 |
Sex and gender differences in clinical pharmacology: implications for transgender medicine LR Cirrincione, KJ Huang Clinical Pharmacology & Therapeutics 110 (4), 897-908, 2021 | 35 | 2021 |
Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy LR Cirrincione, AT Podany, JP Havens, SH Bares, SR Dyavar, Y Gwon, ... Journal of Antimicrobial Chemotherapy 75 (5), 1242-1249, 2020 | 18 | 2020 |
Drug interactions with gender-affirming hormone therapy: focus on antiretrovirals and direct acting antivirals LR Cirrincione, T Senneker, KK Scarsi, A Tseng Expert Opinion on Drug Metabolism & Toxicology 16 (7), 565-581, 2020 | 16 | 2020 |
Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma LR Cirrincione, SD Penchala, KK Scarsi, AT Podany, LC Winchester, ... Journal of Chromatography B 1084, 106-112, 2018 | 16 | 2018 |
A retrospective analysis of creatinine-based kidney function with and without sex assigned at birth among transgender adults SK Fadich, A Kalayjian, DN Greene, LR Cirrincione Annals of Pharmacotherapy 56 (7), 791-799, 2022 | 15 | 2022 |
Limited evidence for use of a black race modifier in eGFR calculations: a systematic review MA Marzinke, DN Greene, PM Bossuyt, AB Chambliss, LR Cirrincione, ... Clinical chemistry 68 (4), 521-533, 2022 | 15 | 2022 |
Sublingual estradiol is associated with higher estrone concentrations than transdermal or injectable preparations in transgender women and gender nonbinary adults LR Cirrincione, G Winston McPherson, J Rongitsch, K Sadilkova, ... LGBT health 8 (2), 125-132, 2021 | 13 | 2021 |
Oral estrogen leads to falsely low concentrations of estradiol in a common immunoassay LR Cirrincione, BO Crews, JA Dickerson, MD Krasowski, J Rongitsch, ... Endocrine Connections 11 (2), 2022 | 10 | 2022 |
Inclusion of transgender and gender diverse people in phase III trials: examples from HIV pharmacologic prevention studies LR Cirrincione, VLB Grieve, J Holloway, MA Marzinke Clinical Pharmacology & Therapeutics 113 (3), 557-564, 2023 | 7 | 2023 |
Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine A Le, KJ Huang, LR Cirrincione Trends in Pharmacological Sciences 43 (7), 582-592, 2022 | 6 | 2022 |
Drug interactions in infectious diseases: antimicrobial drug interactions MP Pai, JJ Kiser, PO Gubbins, KA Rodvold Springer, 2018 | 4 | 2018 |
Drug interactions in HIV: Nucleoside, nucleotide, and nonnucleoside reverse transcriptase inhibitors and entry inhibitors LR Cirrincione, KK Scarsi Drug interactions in infectious diseases: Antimicrobial drug interactions …, 2018 | 4 | 2018 |
Gender-affirming hormone therapy and Bone Health: Do different regimens influence outcomes in transgender adults? A narrative review and call for future studies LR Cirrincione, RR Narla The Journal of Applied Laboratory Medicine 6 (1), 219-235, 2021 | 3 | 2021 |
A holistic framework for the evaluation of kidney function in a gender-diverse landscape KT Miranda, DN Greene, D Collister, MD Krasowski, SB Ahmed, ... American Journal of Kidney Diseases, 2024 | 1 | 2024 |
Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy A Kalayjian, K Laszlo, M Fassler, Z Schonrock, KE Delarose, AM Ly, ... Journal of the American Pharmacists Association 64 (1), 283-289. e2, 2024 | 1 | 2024 |
Clinical Pharmacological Considerations in Transgender Medicine R Coig, VLB Grieve, LR Cirrincione Sex and Gender Effects in Pharmacology, 41-55, 2023 | 1 | 2023 |
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study LR Cirrincione, S Nakalema, CA Chappell, P Byakika-Kibwika, ... Contraception 122, 109975, 2023 | 1 | 2023 |
Drug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals (vol 16, pg 565, 2020) LR Cirrincione, T Senneker, K Scarsi, A Tseng EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 18 (4), 299-299, 2022 | | 2022 |